Very Good Tour Co., Ltd. (KOSDAQ:094850)
4,820.00
-145.00 (-2.92%)
At close: May 20, 2026
Very Good Tour Revenue
Very Good Tour had revenue of 23.10B KRW in the quarter ending March 31, 2024, with 57.56% growth. This brings the company's revenue in the last twelve months to 77.10B, up 182.45% year-over-year. In the year 2023, Very Good Tour had annual revenue of 68.66B with 403.53% growth.
Revenue (ttm)
77.10B
Revenue Growth
+182.45%
P/S Ratio
0.84
Revenue / Employee
240.95M
Employees
n/a
Market Cap
64.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 68.66B | 55.03B | 403.53% |
| Dec 31, 2022 | 13.64B | -48.30B | -77.98% |
| Dec 31, 2012 | 61.93B | 7.15B | 13.05% |
| Dec 31, 2011 | 54.79B | 10.39B | 23.41% |
| Dec 31, 2010 | 44.39B | -2.41B | -5.15% |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CAP Co.,Ltd. | 295.20B |
| Oricom | 227.71B |
| Homecast | 98.00B |
| M2N Co.,Ltd | 86.55B |
| Fine Circuit | 81.79B |
| Sinil Pharmaceutical | 80.56B |
| Assems | 60.27B |
| SG&G Corporation | 47.70B |